• No se han encontrado resultados

Creación y validación de un modelo para el estudio de las lesiones cervicales por accidentes de tráfico

N/A
N/A
Protected

Academic year: 2020

Share "Creación y validación de un modelo para el estudio de las lesiones cervicales por accidentes de tráfico"

Copied!
187
0
0

Texto completo

Loading

Figure

Fig. 2.3 Vértebra cervical de región inferior: a) vista superior; b) vista lateral.  [Atlas 1]
Fig. 2.12 El sistema nervioso: a) la médula espinal  [Sobotta 1993] ; b) el cerebro  [Hasegawa 2003]
Fig. 2.19 Vascularización de la columna vertebral: a)notación empleada en actual modelo; b,c) sección  sagital y transversal según  [Palastanga 2000]
Fig. 3.13 Factores que influyen en la gravedad lesional en lesiones cervicales.
+7

Referencias

Documento similar

Where possible, the EU IG and more specifically the data fields and associated business rules present in Chapter 2 –Data elements for the electronic submission of information

The 'On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services' document must be considered the reference guidance, as this document includes the

In medicinal products containing more than one manufactured item (e.g., contraceptive having different strengths and fixed dose combination as part of the same medicinal

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

This section provides guidance with examples on encoding medicinal product packaging information, together with the relationship between Pack Size, Package Item (container)

Package Item (Container) Type : Vial (100000073563) Quantity Operator: equal to (100000000049) Package Item (Container) Quantity : 1 Material : Glass type I (200000003204)

If certification of devices under the MDR has not been finalised before expiry of the Directive’s certificate, and where the device does not present an unacceptable risk to health